Literature DB >> 1863851

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.

W J Gullick1.   

Abstract

This chapter reviews briefly the prevalence of overexpression of the epidermal growth factor receptor in human cancers. In addition, it examines the mechanisms responsible for increased expression and its clinical significance.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1863851     DOI： 10.1093/oxfordjournals.bmb.a072464

Source DB:  PubMed          Journal:  Br Med Bull        ISSN： 0007-1420            Impact factor:   4.291


  102 in total

1.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  Monoclonal antibody (MAB) in patients with advanced cancer.

Authors:  Hyung L Kim; Allan J Pantuck; Nazy Zomorodian; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

Review 3.  Growth factors in the gastrointestinal tract.

Authors:  N R Lemoine; H Y Leung; W J Gullick
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

4.  Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus.

Authors:  J Jankowski; G Coghill; D Hopwood; K G Wormsley
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

5.  EGFR regulation of colon cancer stem-like cells during aging and in response to the colonic carcinogen dimethylhydrazine.

Authors:  Jyoti Nautiyal; Jianhua Du; Yingjie Yu; Shailender S Kanwar; Edi Levi; Adhip P N Majumdar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-26       Impact factor: 4.052

6.  Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.

Authors:  M Alimandi; L M Wang; D Bottaro; C C Lee; A Kuo; M Frankel; P Fedi; C Tang; M Lippman; J H Pierce
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

7.  α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation.

Authors:  Haitao Ji; Ji Wang; Bingliang Fang; Xuexun Fang; Zhimin Lu
Journal:  J Neurooncol       Date:  2010-09-26       Impact factor: 4.130

Review 8.  Direct cell killing by suicide genes.

Authors:  L A Martin; N R Lemoine
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

9.  Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells.

Authors:  Imoh S Okon; Kathleen A Coughlan; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

10.  New platform for controlled and sustained delivery of the EGF receptor tyrosine kinase inhibitor AG1478 using poly(lactic-co-glycolic acid) microspheres.

Authors:  Rebecca Robinson; James P Bertram; Jill L Reiter; Erin B Lavik
Journal:  J Microencapsul       Date:  2010-05       Impact factor: 3.142
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.